Cellular and molecular mechanisms of gastrointestinal ulcer healing

Digestive Diseases and Sciences

Volumn 50, Issue SUPPL. 1, 2005, Pages

  Tarnawski, Andrzej S ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gene therapy; Granulation tissue; Growth factor; Re epithelialization; Signaling

Indexed keywords

ACTIN; ANGIOPOIETIN; ANGIOPOIETIN 1; COMPLEMENTARY DNA; CYCLOOXYGENASE 2; ENDOTHELIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1; KERATINOCYTE GROWTH FACTOR; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C GAMMA; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; RAC PROTEIN; RAS PROTEIN; RHO FACTOR; SCATTER FACTOR; SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CELL GROWTH FACTOR 165; VASCULOTROPIN;

ANGIOGENESIS; CELL DIFFERENTIATION; CELL DIVISION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CYTOSKELETON; DIGESTIVE SYSTEM ULCER; DUODENUM ULCER; EPITHELIUM CELL; EPITHELIZATION; ESOPHAGUS ULCER; EXTRACELLULAR MATRIX; GENE ACTIVATION; GENE EXPRESSION; GENETIC CODE; GRANULATION TISSUE; HUMAN; HYPOXIA; INFLAMMATION; MESENCHYME CELL; MOLECULAR MECHANICS; NONHUMAN; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUALITY CONTROL; REVIEW; SCAR FORMATION; SIGNAL TRANSDUCTION; STEM CELL; STOMACH ULCER; TISSUE ENGINEERING; TISSUE INJURY; TISSUE REGENERATION; ULCER HEALING;

CELL PROLIFERATION; CELL SURVIVAL; CICATRIX; CYTOKINES; CYTOSKELETON; GASTRIC MUCOSA; GROWTH SUBSTANCES; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION; STOMACH ULCER; WOUND HEALING;

EID: 25644437787     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2803-6     Document Type: Review

References (54)

1. Cotran RS, Kumar V, Robbins SL: Gastric ulceration. In Robbins Pathologic Basis of Disease. 5th Edition. RS Cotran, V Kumar, SL Robbins (eds). Philadelphia, Saunders, 1999, pp 298-299, 773-777
2. Tarnawski A: Cellular mechanisms of gastric ulcer healing. In The Stomach. W Domschke, SJ Konturek (eds). Berlin New York, Springer, 1993, pp 177-192
3. Tarnawski A: Molecular mechanism of ulcer healing. Drug News Perspect 13:158-168, 2000
4. Tarnawski A, Hollander D, Stachura J, et al.: Vascular and microvascular changes - key factors in the development of acetic acid-induced gastric ulcers in rats. J Clin Gastroenterol 12(1):S148-S157, 1990
5. Baatar D, Kawanaka H, Szabo IL, Pai R, Jones MK, Kitano S, Tarnawski AS: Esophageal ulceration activates genes encoding keratinocyte growth factor and its receptor in rats: a key to esophageal ulcer healing? Gastroenterology 122:458-468, 2002
6. The Molecular and Cellular Biology of Wound Repair. 2nd Edn. RAF Clark (ed). Plenum Press, New York, 1996
7. Tarnawski A, Hollander D, Krause WJ, Dabros W, Stachura J, Gergely H: "Healed" experimental gastric ulcers remain histologically and ultrastructurally abnormal. J Clin Gastroenterol 12(Suppl 1):139-147, 1990
8. Tarnawski A, Stachura J, Krause WJ, Douglass TG, Gergely H: Quality of gastric ulcer healing - a new, emerging concept. J Clin Gastroenterol 13(1):S42-S47, 1991
9. Vanwijck R: Surgical biology of wound healing. Bull Mem Acad R Med Belg 56(3-4):175-184, 2001
10. Taupin D, Wu D-C, Jeon W-K, Devaney K, Wang TC, Podolsky DK: The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor-and MAP kinase-dependent interregulation. J Clin Invest 103:R31-R38, 1990
11. Wong WM, Playford RJ, Wright NA: Peptide gene expression in gastrointestinal mucosal ulceration: ordered sequence or redundancy? Gut 46:286-292, 2000
12. Tarnawski A, Stachura J, Durbin T, Sarfeh IJ, Gergely H: Increased expression of epidermal growth factor receptor during gastric ulcer healing rats. Gastroenterology 102:695-698, 1992
13. Wright NA, Pike C, Elia G: Induction of a novel epidermal growth factor-secreting cell lineage mucosal ulceration in human gastrointestinal stem cells. Nature 343:82-85, 1990
14. Tarnawski A, Jones K: The role of EGF and its receptor in mucosal protection, adaptation to injury and ulcer healing. Involvement of EGF-R signal transduction pathways. J Clin Gastroenterol 27:S12-S20, 1998
15. Okamoto R, Yajima T, Yamazaki M, Kani T, Mukai M, Okamoto S, Ikeda Y, Hibi T, Inazawa J, Watanabe M: Damaged epithelial regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nature Med 8:1011-1017, 2002
16. Chai J, Baatar D, Tarnawski AS: Serum response factor promotes re-epithelialization and muscular structure restoration during gastric ulcer healing. Gastroenterology 126:1809-1818, 2004
17. Stossel TP: On the crawling of animal cells. Science 260:1986-1994, 1993
18. Schliwa M: The cytoskeleton. Vienna New York, Springer, 1986, p 326
19. Polk DB: Epithelial growth factor receptor stimulated intestinal epithelial cell migration requirements phospholipase C activity. Gastroenterology 114:493-502, 1998
20. Bornfeldt KE, Rainses EW, Graves EM, Skinne MP, Krebs EG, Ross R: Platelet derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation. Ann NY Acad Sci 766:416-430, 1995
21. Pai R, Ohta M, Itani RM, Sarfeh IJ, Tarnawski AS: Induction of mitogen activated protein kinase signal transduction pathway during gastric ulcer healing in rat model. Gastroenterology 114:706-713, 1998
22. Tarnawski A, Pai R: Translocation of MAP (ERK-1 and -2) kinases to cell nuclei and activation of c-fos gene during healing of experimental gastric ulcer. J Physiol Pharmacol 49:479-187, 1998
23. Pai R, Jones MK, Tomikawa M, Tarnawski AS: Activation of Raf-1 during experimental gastric ulcer healing is ras-mediated and protein kinase C-independent. Am J Pathol 155:1759-1766, 1999
24. Tarnawski A, Hollander D, Stachura J, Gergely H, Krause WJ, Sarfeh IJ: Role of angiogenesis in healing of experimental gastric ulcer. In Mechanisms of Peptic Ulcer Healing. F Halter, A Garner, GNJ Tytgat (eds). Dordrecht/Boston/ Eondon, Kluwer, 1991, pp 165-171
25. Risau W: Mechanisms of angiogenesis. Nature 386:671-73, 1997
26. Folkman J, D'Amore PA: Blood vessel formation: what is its molecular basis? Cell 87:1153-1155, 1996
27. Ferrara N: Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581-611, 2004
28. Chai J, Baatar D, Tarnawski AS: Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis: insight into the mechanisms. FASEB J 18:1264-1266, 2004
29. Folkman J, Szabo S, Stovroff M, McNeil P, Li W, Shing Y: Duodenal ulcer. Discovery of a new mechanisms and development of angiogenic therapy that accelerates healing. Ann Surg 214:414-127, 1991
30. Szabo S, Folkman J, Vattay P, et al.: Accelerated healing of duodenal ulcers by oral administration of basic fibroblast growth factors in rats. Gastroenterology 106:1106-1111, 1994
31. Szabo S, Folkman J, Vincze A, Sandor ZS, Gombos A: Modulation of vascular factors by VEGF/VPF is sufficient for chronic ulcer healing and acute gastroprotection. Gastroenterology 122:A303, 1997
32. Jones MK, Itani RM, Wang H, Tomikawa S, Sarfeh IJ, Szabo S, Tarnawski A: Activation of VEGF and Ras genes in gastric mucosa during angiogenic response to ethanol injury. Am J Physiol 276(39):G1345-G1355, 1999
33. Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS: Inhibition of angiogenesis by NSAIDs. Insight into the mechanisms and implications for cancer growth and ulcer healing. Nature Med 5:1418-1423, 1999
34. Davis S, Aldrich TH, Jones PF, et al.: Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161-1169, 1996
35. Suri C, Jones PF, Patan S, et al.: Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180, 1996
36. Maisonpierre PC, Suri C, Jones PF, et al.: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60, 1997
37. Procopio WN, Pelavin PI, Lee WMF, Yeildong NM: Angiopoietin-1 and -2 coiled coil domains mediate distinct oligomerization patterns, but fibrinogen-like domains mediate ligand activity. J Biol Chem 274:30196-30201, 1999
38. Oh H, Takagi H, Suzuma K, Otani A, et al.: Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 274:15723-15739, 1997
39. Tarnawski A, Pai R, Jones MK, Szabo I, Sarfeh IJ: Gastric ulceration triggers activation of angiopoietin-1, -2 and Tie2 important for angiogenesis. Gastroenterology 118:A242, 2000
40. Wen CY, Ito M, Chen L-D, Matsuu M, Shichijo K, Nakayama T, Nakashima M, Xu Z-M, Ohtsuru A, Hsu C-T, Sekine I: Expression of Tie-2 and angiopoietin-1 and -2 in early phase of ulcer healing. J Gastroenterol 38:431-435, 2003
41. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt AB, Dixit V, Ferrara N: Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 13;273(46):30336-30343, 1998
42. Basson MD, Modlin IM, Turowski G, Madri JA: Enterocyte-matrix interactions in the healing of mucosal injury. Euro J Gastroenterol Hepatol 5(Suppl 3):S21-S28, 1993
43. Basson MD: In vitro evidence for matrix regulation of intestinal epithelial biology during mucosal healing. Life Sci 69:3005-3018, 2001
44. Shanin M, Konturek JW, Pohle T, Schuppan D, Herbst H, Domschke W: Remodeling of extracellular matrix in gastric ulceration. Microsc Res Technol 53(6):396-408, 2001
45. Calabro A, Grappone C, Pellegrini G, Evangelista S, Tramontana M, Schuppan D, Herbst H, Milani S: Spatial and temporal pattern of expression of interstitial collagenase, stromelysin/transin, gelatinase A, and TIMP-1 during experimental gastric ulcer healing. Digestion 70:127-138, 2004
46. Pai R, Wyle FA, Cover TL, Itani RM, Tarnawski A: H. pylori culture supernatant interferes with EGF-activated signal transduction in human gastric Kato III cells. Am J Pathol 152:1617-1624, 1998
47. Tarnawski AS, Jones MK: Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications. J Mol Med 81:627-636, 2003
48. Schmassmann A, Tarnawski A, Flogerzi B, Sanner M, Varga Halter LF: Antacids in experimental gastric ulcer healing: pharmacokinetics of aluminum and quality of healing. Eur J Gastroenterol Hepatol 5(3):S14-S16, 1993
49. Tarnawski A, Arakawa Kobayashi TK: Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa. The key mechanisms for its ulcer healing action? Dig Dis Sci 43(9):90S-98S, 1998
50. Arakawa T, Nebiki H, Uchida T, Kimura S, Higuchi K, Kobayashi K: Clinical assessment of quality of ulcer healing: a new endoscopic approach. Eur J Gastroenterol Hepatol 5:S87-S92, 1993
51. Jones MK, Kawanaka H, Baatar D, Szabo IL, Pai, R, Koh GY, Kim I, Sarfeh IJ, Tarnawski AS: Gene therapy for gastric ulcers. With single local injection of VEGF naked DNA encoding VEGF and angiopoietin-1. Gastroenterology 121:1040-1047, 2001
52. Baatar D, Jones MK, Tsugawa K, Koh Gy, Kim I, Kitano S, Tarnawski AS: Esophageal ulceration triggers expression of hypoxia-inducible factor-1α and activates vascular endothelial growth factor gene. Am J Pathol 161:1449-1457, 2002
53. Szabo S, Deng X, Khomenko T, Yoshida M, Jadus MR, Sandor Z, Gombos Z, Matsumoto H: Gene expression and gene therapy in experimental duodenal ulceration. J Physiol Paris 95(1-6):325-335, 2001
54. Deng X, Szabo S, Khomenko T, Jadus MR, Yoshida M: Gene therapy with adenoviral plasmids or naked DNA of VEGF PDGF accelerates healing of duodenal ulcer in rats. J Pharmacol Exp Ther 311:982-988, 2004